Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

about

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.

P2860

Q41561479-1D98998D-5147-4671-B070-A8F77B763017

P2860

Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q41396044

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of pomalidomide on rela ...... atic review and meta-analysis.

@en

type

Item

label

Effect of pomalidomide on rela ...... atic review and meta-analysis.

@en

prefLabel

Effect of pomalidomide on rela ...... atic review and meta-analysis.

@en

P1476

Effect of pomalidomide on rela ...... atic review and meta-analysis.

@en

P2093

Baoan Chen

http://www.w3.org/2001/XMLSchema#string

Chengxin Luan

http://www.w3.org/2001/XMLSchema#string

Chong Gao

http://www.w3.org/2001/XMLSchema#string

Runzhe Chen

http://www.w3.org/2001/XMLSchema#string

Yujie Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials

Novel agents in the treatment of multiple myeloma: a review about the future

Treatment of relapsed and refractory multiple myeloma

Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives

Multiple myeloma: from front-line to relapsed therapies

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Novel therapeutic strategies for multiple myeloma

Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myeloma

Efficacy of carfilzomib in the treatment of relapsed and (or) refractory multiple myeloma: a meta-analysis of data from clinical trials.

P304

1801-1808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.17999

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiao-Ping Zhang

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28819377

http://www.w3.org/2001/XMLSchema#string

P932

5556643

http://www.w3.org/2001/XMLSchema#string

Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

about

P2860

P2860

Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932